Growth Metrics

Armata Pharmaceuticals (ARMP) Other Non-Current Assets (2018 - 2026)

Quarterly results put Other Non-Current Assets at $4.1 million for Q1 2026, down 23.56% from a year ago — trailing twelve months through Mar 2026 was $4.1 million (down 23.56% YoY), and the annual figure for FY2025 was $5.4 million, up 452.82%.

Armata Pharmaceuticals has reported Other Non-Current Assets over the past 11 years, most recently at $4.1 million for Q1 2026.

  • Other Non-Current Assets reached $4.1 million in Q1 2026 per ARMP's latest filing, down from $5.4 million in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $6.0 million in Q1 2022 and bottomed at $973000.0 in Q2 2025.
  • Median Other Non-Current Assets over the past 5 years was $5.5 million (2024), compared with a mean of $5.0 million.
  • The largest annual shift saw Other Non-Current Assets plummeted 82.95% in 2024 before it surged 452.82% in 2025.
  • Over 5 years, Other Non-Current Assets stood at $6.0 million in 2022, then fell by 4.03% to $5.7 million in 2023, then tumbled by 82.95% to $975000.0 in 2024, then soared by 452.82% to $5.4 million in 2025, then decreased by 23.56% to $4.1 million in 2026.
  • Business Quant data shows Other Non-Current Assets for ARMP at $4.1 million in Q1 2026, $5.4 million in Q4 2025, and $5.4 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Quantum Biopharma 1,384,976.65 Bn 1,384,976.64 Bn - -
2 Alterity Therapeutics 777,208.84 Bn 777,208.81 Bn - -
3 Legend Biotech 2,801.00 Bn 2,800.10 Bn 242.10 Mn 12.40 Mn
4 Nanobiotix 2,226.01 Bn 2,225.95 Bn - -
5 Akari Therapeutics 605.66 Bn 605.66 Bn - 60,000.00
6 Vertex Pharmaceuticals 110.17 Bn 102.92 Bn 2.59 Bn 1.26 Bn
7 Regeneron Pharmaceuticals 66.86 Bn 58.11 Bn 3.31 Bn 2.13 Bn
8 Evaxion A 65.12 Bn 65.10 Bn - -
9 Alnylam Pharmaceuticals 39.94 Bn 36.94 Bn 959.66 Mn 63.55 Mn
10 Armata Pharmaceuticals 301.92 Mn 297.17 Mn - 4.12 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 4.12 Mn
Dec 31, 2025 5.39 Mn
Sep 30, 2025 5.39 Mn
Jun 30, 2025 973,000.00
Mar 31, 2025 5.39 Mn
Dec 31, 2024 975,000.00
Sep 30, 2024 5.48 Mn
Jun 30, 2024 5.48 Mn
Mar 31, 2024 5.48 Mn
Dec 31, 2023 5.72 Mn
Sep 30, 2023 5.82 Mn
Jun 30, 2023 5.72 Mn
Mar 31, 2023 5.72 Mn
Dec 31, 2022 5.96 Mn
Sep 30, 2022 5.96 Mn
Jun 30, 2022 5.96 Mn
Mar 31, 2022 5.96 Mn
Dec 31, 2021 1.20 Mn
Sep 30, 2021 1.20 Mn
Jun 30, 2021 1.20 Mn
Mar 31, 2021 1.20 Mn
Dec 31, 2020 1.20 Mn
Sep 30, 2020 1.20 Mn
Jun 30, 2020 1.20 Mn
Mar 31, 2020 600,000.00
Dec 31, 2019 135,000.00
Sep 30, 2019 700,000.00
Jun 30, 2019 700,000.00
Mar 31, 2019 700,000.00
Dec 31, 2018 136,000.00
Sep 30, 2018 800,000.00
Jun 30, 2018 800,000.00